Skip to search.
 FTSE 100 Down 1.22%

VIVUS Inc. (VVUS)

-NasdaqGS
1.41 Down 0.10(6.33%) 16:35 - Nasdaq Real Time Price
Prev Close:1.50
Open:1.50
Bid:1.37 x 800
Ask:1.38 x 1500
1y Target Est:7.27
Beta:0.815254
Earnings Date:28 Jul - 1 Aug (Est.)
Day's Range:1.35 - 1.52
52wk Range:0.92 - 2.65
Volume:556,171
Avg Vol (3m):1,049,500
Market Cap:146.25m
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for VVUS at this time.

Comparison

Symbol% ChgMkt Cap
VVUSDown 6.33%146.25m
LLYDown 1.54%79.81b
PFEDown 0.10%208.46b
GSKDown 1.97%102.34b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.50
Quarterly EPS Est (Jun-16) :-0.21
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-3.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback